Human normal immunoglobulin (Takeda)

N/A

Report date: 2026/01/30 10:15:04

Base Information

Drug NameHuman normal immunoglobulin (Takeda)
Drug Alias NameDeqsigaGAMMAGARD ERCGAMMAGARD LIQUID ERCTAK880TAK-880
ClassificationBiologics > Protein drugs > Immunoglobulin
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsImmunologic Deficiency SyndromesPrimary Immunodeficiency DiseasesPurpura, Thrombocytopenic, Idiopathic +[6] 
Global Approved IndicationsImmunologic Deficiency SyndromesPrimary Immunodeficiency DiseasesPurpura, Thrombocytopenic, Idiopathic +[6] 
Approved Indications in ChinaN/A
Original Approved Country/TerritoryEU
Original Approved Date2025/05/02
Country/TerritoryUnited StatesEU
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesTakeda Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesTakeda Manufacturing Austria AgTakeda Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsImmunologic Deficiency SyndromesPrimary Immunodeficiency DiseasesPurpura, Thrombocytopenic, Idiopathic +[6] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A